Form 4 for ICE Intercontinental Exchange
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001193125-26-059907 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-02-19 | 2026-02-18 | ICE | Sprecher Jeffrey C | CEO, Dir | M - OptEx | $67.23 | +52.1K | 1.22M | +4% | +$3.50M |
| DTI | 2026-02-19 | 2026-02-18 | ICE | Sprecher Jeffrey C | CEO, Dir | S - Sale+OE | $155.00 | -150.0K | 1.65M | -8% | -$23.25M |
| DT | 2026-02-19 | 2026-02-18 | ICE | Sprecher Jeffrey C | CEO, Dir | S - Sale+OE | $155.00 | -129.9K | 1.09M | -11% | -$20.14M |
| DT | 2026-02-19 | 2026-02-17 | ICE | Sprecher Jeffrey C | CEO, Dir | F - Tax | $152.28 | -6,459 | 1.17M | -0.5% | -$983.6K |
| DMT | 2026-02-19 | 2026-02-18 | ICE | Sprecher Jeffrey C | CEO, Dir | M - OptEx | $0.00 | -52.1K | 101.5K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | M | A | 50,766 | $67.00 | 1,223,547 | D | — | — | (F2) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. |
| 2 | Common | Common Stock | 2026-02-18 | S | D | 150,000 | $155.00 | 1,651,705 | I | — | — | (F2) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. (F6) As previously reported, the reporting person also indirectly owns 1,651,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. |
| 3 | Common | Common Stock | 2026-02-18 | S | D | 129,937 | $155.00 | 1,094,923 | D | — | — | (F2) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. (F5) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. (F4) The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. (F3) The common stock number referred in Table I is an aggregate number and represents 1,034,643 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. |
| 4 | Common | Common Stock | 2026-02-17 | F | D | 6,459 | $152.28 | 1,172,781 | D CPEX | — | — | (F1) Represents shares of performance based restricted stock units granted to the filing person on February 12, 2024. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2024 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2025, 1/3 on February 15, 2026 and 1/3 on February 15, 2027). Of the 42,792 shares, 14,264 were issued on February 17, 2026, of which 6,459 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 14,264 shares are scheduled to be issued on February 12, 2027 and taxes for this future issuance will be withheld and reported at the time the shares are issued. |
| 5 | Common | Common Stock | 2026-02-18 | M | A | 1,313 | $76.16 | 1,224,860 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) Holding | 2026-02-18 | M | D | 1,313 | $0.00 | 137,845 | D | $76.16 · — to 2029-02-08 | 1,313 Common Stock | (F8) These options are fully vested. |
| 7 | Derivative | Employee Stock Option (right to buy) Holding | 2026-02-18 | M | D | 50,766 | $0.00 | 101,533 | D | $67.00 · — to 2028-02-08 | 50,766 Common Stock | (F8) These options are fully vested. |